Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients

Marc G Jeschke1, David L Chinkes, Celeste C Finnerty

  • 1Shriners Hospitals for Children and Department of Surgery, University of Texas Medical Branch, Galveston, TX, USA.

Critical Care Medicine
|January 6, 2007
PubMed

Insights

Severely burned children receiving extensive blood transfusions, especially packed red blood cells (RBCs), face a significantly higher risk of developing sepsis. This highlights a potential link between blood product administration and sepsis development in pediatric burn patients.

Area of Science:

  • Pediatric critical care medicine
  • Burn injury management
  • Transfusion medicine

Background:

  • Sepsis is a life-threatening complication in severely burned patients.
  • The role of blood product transfusion in the development of sepsis in pediatric burn patients is not fully understood.

Purpose of the Study:

  • To investigate the association between the volume of blood products transfused and the incidence of sepsis in pediatric patients with severe burns.
  • To identify risk factors for sepsis development post-transfusion in this vulnerable population.

Main Methods:

  • Retrospective cohort study involving severely burned pediatric patients (>30% total body surface area [TBSA] burn).
  • Patients were stratified by TBSA burn, inhalation injury, and transfusion volume (packed red blood cells [RBCs], fresh frozen plasma [FFP]).
  • Sepsis diagnosis followed established criteria, including positive blood cultures.

Main Results:

  • Patients with >60% TBSA burn and inhalation injury receiving high amounts of RBCs (>20 units) had a 58% sepsis risk, compared to 8% in the low RBC group (<20 units).
  • Similar trends were observed for FFP transfusion volumes and normalized values per operation (p<.05).
  • No significant differences in age or gender were noted between transfusion groups.

Conclusions:

  • High-volume blood product transfusion, particularly RBCs, is associated with an increased risk of sepsis in pediatric burn patients with extensive burns and inhalation injuries.
  • These findings suggest that extensive transfusions may contribute to an immunocompromised state, increasing sepsis susceptibility.
Abstract

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...